AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 1 filers reported holding AMRYT PHARMA PLC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,093,500 | – | 75,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 765,236 | $9,458,000 | 9.84% |
| Global Frontier Investments LLC | 125,000 | $1,545,000 | 2.28% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 676,034 | $8,281,000 | 0.45% |
| EdgePoint Investment Group Inc. | 2,293,180 | $28,344,000 | 0.32% |
| Context Partners Fund, L.P. | 69,437 | $858,000 | 0.19% |
| Context Capital Management, LLC | 69,437 | $858,000 | 0.19% |
| WHITEBOX ADVISORS LLC | 271,624 | $3,341,000 | 0.14% |
| ARMISTICE CAPITAL, LLC | 306,000 | $3,782,000 | 0.14% |
| AMERIPRISE FINANCIAL INC | 716,895 | $8,817,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 302 | $4,000 | 0.00% |